首页> 美国卫生研究院文献>JNMA: Journal of the Nepal Medical Association >Approach to Sample Collection Transport and Processing of Suspected or Confirmed COVID-19 Patients for Biochemistry Investigations
【2h】

Approach to Sample Collection Transport and Processing of Suspected or Confirmed COVID-19 Patients for Biochemistry Investigations

机译:涉嫌或确认的生物化学调查的涉嫌或证实Covid-19患者的样本运输和处理的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

During this global pandemic period of COVID-19, the health care system is the most affected area. Health care workers including the clinicians, laboratory professional and other allied health workers pose a high threat for acquiring and transmission of the disease. Apart from the diagnosis of disease by the RT-PCR, other laboratory investigations are equally essential in disease prognosis and monitoring. This biosafety guidance is intended to provide and insight to the clinicians, nurses and laboratory professionals in handling the blood and other body fluid samples for biochemical investigations concerning the proper methods of sample collection, transport, processing and disposal. Every day, the laboratory receives samples of the patient with confirmed and suspected cases of COVID-19 patients. This pose a high threat of contamination to the health professionals and thus, a proper risk assessment and standard precautions protocol must be followed to ensure safety, minimize the risk of contamination and disease transmission.
机译:在Covid-19的全球大流行期间,医疗保健系统是受影响最大的地区。保健工作者包括临床医生,实验室专业和其他盟军卫生工作者对疾病的获取和传播具有高威胁。除了RT-PCR诊断外,其他实验室研究在疾病预后和监测中同样是必不可少的。这种生物安全指南旨在为临床医生,护士和实验室专业人员提供和洞察,用于处理有关样品收集,运输,加工和处置的适当方法的生化研究的生化调查的血液和其他体液样本。每天,实验室接受患者的样品,确诊和疑似Covid-19患者病例。这对健康专业人员构成了高度污染威胁,因此,必须遵守适当的风险评估和标准预防措施议定书,以确保安全,尽量减少污染和疾病传播的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号